Literature DB >> 10583290

Role of nitric oxide in intestinal ischaemia-reperfusion injury studied using electron paramagnetic resonance.

K L Chan1, X H Zhang, P C Fung, W H Guo, P K Tam.   

Abstract

BACKGROUND: The role of nitric oxide in intestinal ischaemia-reperfusion (I/R) remains poorly defined, partly because of difficulty in detecting the nitric oxide free radical. In this study nitric oxide production was assessed during intestinal I/R by direct measurement using electron paramagnetic resonance (EPR), and the production of nitric oxide in jejunum and ileum was correlated with their different abilities to resist I/R injury.
METHODS: Rats were given an electron spin trapper (diethyldithiocarbamate/ferrous citrate) by intraperitoneal injection. Thirty-six segments each of jejunum and ileum were subjected to 15-90 min of ischaemia and 25 min of reperfusion. Tissue samples were analysed for EPR signals using a spectrometer.
RESULTS: Mean(s.d.) basal nitric oxide level was significantly higher in ileum (3.39(1.42) units) than jejunum (0. 65(0.05) units) (P = 0.0005). Increasing ischaemic times in the ileum resulted in decreasing nitric oxide levels (85, 32 and 13 per cent of basal level at 30, 60 and 90 min respectively); reperfusion resulted in further nitric oxide reduction (mean decrease 26 per cent). Severe (grade 3) histological damage was observed in low nitric oxide states (after 15 min of I/R in jejunum, 60 min of I/R in ileum).
CONCLUSION: Nitric oxide can be measured in intestinal tissues directly by EPR. The findings support a protective role for nitric oxide in I/R, and offer an explanation for the greater resistance to I/R of ileum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583290     DOI: 10.1046/j.1365-2168.1999.01241.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Structural and neuronal changes in rat ileum after ischemia with reperfusion.

Authors:  Lille-Mor Lindeström; Eva Ekblad
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 2.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

3.  Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents.

Authors:  Fiore Cattaruzza; Nicolas Cenac; Elisabetta Barocelli; Mariannina Impicciatore; Eric Hyun; Nathalie Vergnolle; Catia Sternini
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

4.  Umbilical mesenchymal stromal cells provide intestinal protection through nitric oxide dependent pathways.

Authors:  Amanda R Jensen; Natalie A Drucker; Michael J Ferkowicz; Troy A Markel
Journal:  J Surg Res       Date:  2017-12-28       Impact factor: 2.192

5.  Quantitative assessment of intestinal injury using a novel in vivo, near-infrared imaging technique.

Authors:  Todd W Costantini; Brian P Eliceiri; Carrie Y Peterson; William H Loomis; James G Putnam; Andrew Baird; Paul Wolf; Vishal Bansal; Raul Coimbra
Journal:  Mol Imaging       Date:  2010-02       Impact factor: 4.488

6.  Acute colonic ischaemia in rats results in long-term structural changes without alterations of colonic sensitivity.

Authors:  Anna Ravnefjord; Madeleine Pettersson; Erika Rehnström; Vicente Martinez
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

7.  Pretreatment of Mesenchymal Stem Cells Manipulates Their Vasculoprotective Potential While Not Altering Their Homing Within the Injured Gut.

Authors:  Dean P J Kavanagh; Shankar Suresh; Philip N Newsome; Jon Frampton; Neena Kalia
Journal:  Stem Cells       Date:  2015-06-29       Impact factor: 6.277

8.  Sodium nitroprusside as a nitric oxide donor in a rat intestinal ischemia-reperfusion model.

Authors:  Ali Emre; Orhan Bayram; Bulent Salman; Sevim Ercan; Ziya Anadol; Okhan Akin
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.